Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC, 53917-53922 [2023-17036]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 152 / Wednesday, August 9, 2023 / Notices
[Investigation Nos. 701–TA–442 and 731–
TA–1095–1096 (Third Review)]
Lined Paper School Supplies From
China and India
Determinations
On the basis of the record 1 developed
in the subject five-year reviews, the
United States International Trade
Commission (‘‘Commission’’)
determines, pursuant to the Tariff Act of
1930 (‘‘the Act’’), that revocation of the
countervailing duty order on lined
paper school supplies from India and
the antidumping duty orders on lined
paper school supplies from China and
India would be likely to lead to
continuation or recurrence of material
injury to an industry in the United
States within a reasonably foreseeable
time.
Background
The Commission instituted these
reviews on February 1, 2023 (88 FR
6787) and determined on May 8, 2023
that it would conduct expedited reviews
(88 FR 37096, June 6, 2023).
The Commission made these
determinations pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)). It
completed and filed its determinations
in these reviews on August 4, 2023. The
views of the Commission are contained
in USITC Publication 5450 (August
2023), entitled Lined Paper School
Supplies from China and India:
Investigation Nos. 701–TA–442 and
731–TA–1095–1096 (Third Review).
By order of the Commission.
Issued: August 4, 2023.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2023–17085 Filed 8–8–23; 8:45 am]
BILLING CODE 7020–02–P
JUDICIAL CONFERENCE OF THE
UNITED STATES
Advisory Committees on Appellate,
Bankruptcy, and Civil Rules; Hearings
of the Judicial Conference
Judicial Conference of the
United States.
ACTION: Advisory Committees on
Appellate, Bankruptcy, and Civil Rules;
notice of proposed amendments and
open hearings.
AGENCY:
lotter on DSK11XQN23PROD with NOTICES1
All written comments and
suggestions with respect to the proposed
amendments may be submitted on or
after the opening of the period for
public comment on August 15, 2023,
but no later than February 16, 2024.
ADDRESSES: Written comments must be
submitted electronically, following the
instructions provided on the website.
Comments will be posted on the website
and available to the public.
Public hearings either virtually or in
person are scheduled on the proposed
amendments as follows:
• Appellate Rules on October 18,
2023, and January 24, 2024;
• Bankruptcy Rules and Forms on
January 12, 2024, and January 19, 2024;
and
• Civil Rules on October 16, 2023,
January 16, 2024, and February 6, 2024.
Those wishing to testify must contact
the Secretary of the Committee on Rules
of Practice and Procedure by email at:
RulesCommittee_Secretary@
ao.uscourts.gov, at least 30 days before
the hearing.
FOR FURTHER INFORMATION CONTACT: H.
Thomas Byron III, Esq., Chief Counsel,
Rules Committee Staff, Administrative
Office of the U.S. Courts, Thurgood
Marshall Federal Judiciary Building,
One Columbus Circle NE, Suite 7–300,
Washington, DC 20544, Phone (202)
502–1820, RulesCommittee_Secretary@
ao.uscourts.gov.
DATES:
INTERNATIONAL TRADE
COMMISSION
The
Advisory Committees on Appellate,
Bankruptcy, and Civil Rules have
proposed amendments to the following
rules:
• Appellate Rules 6 and 39;
• Bankruptcy Rules 3002.1 and 8006;
• Bankruptcy Official Forms 410,
410C13–M1, 410C13–M1R, 410C13–N,
410C13–NR, 410C13–M2, and 410C13–
M2R; and
• Civil Rules 16, 26, and new Rule
16.1.
SUPPLEMENTARY INFORMATION:
The text of the proposals will be
posted August 15, 2023, on the
Judiciary’s website at: https://
www.uscourts.gov/rules-policies/
proposed-amendments-publishedpublic-comment.
(Authority: 28 U.S.C. 2073.)
Dated: August 3, 2023.
Shelly L. Cox,
Management Analyst, Rules Committee Staff.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1238]
Bulk Manufacturer of Controlled
Substances Application: Chemtos,
LLC
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Notice of application.
Chemtos, LLC has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before October 10, 2023. Such
persons may also file a written request
for a hearing on the application on or
before October 10, 2023.
DATES:
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on July 6, 2023, Chemtos,
LLC., 16713 Picadilly Court, Round
Rock, Texas 78664–8544, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
[FR Doc. 2023–16976 Filed 8–8–23; 8:45 am]
BILLING CODE 2210–55–P
1 The record is defined in § 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
VerDate Sep<11>2014
18:19 Aug 08, 2023
Jkt 259001
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
53917
E:\FR\FM\09AUN1.SGM
09AUN1
53918
Federal Register / Vol. 88, No. 152 / Wednesday, August 9, 2023 / Notices
lotter on DSK11XQN23PROD with NOTICES1
Controlled substance
Drug code
Amineptine .......................................................................................................................................................................
Mesocarb .........................................................................................................................................................................
3-Fluoro-N-methylcathinone (3-FMC) ..............................................................................................................................
Cathinone ........................................................................................................................................................................
Methcathinone .................................................................................................................................................................
4-Fluoro-N-methylcathinone (4-FMC) ..............................................................................................................................
Pentedrone (a-methylaminovalerophenone) ...................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
4-Methyl-N-ethylcathinone (4-MEC) ................................................................................................................................
Naphyrone .......................................................................................................................................................................
N-Ethylamphetamine .......................................................................................................................................................
Methiopropamine .............................................................................................................................................................
N,N-Dimethylamphetamine ..............................................................................................................................................
Fenethylline .....................................................................................................................................................................
Aminorex ..........................................................................................................................................................................
4-Methylaminorex (cis isomer) ........................................................................................................................................
Gamma Hydroxybutyric Acid ...........................................................................................................................................
Methaqualone ..................................................................................................................................................................
Mecloqualone ..................................................................................................................................................................
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ...................................................................................................
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) .................................................
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .............
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone .................
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ......................
FUB-144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) ...............................................
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) .......................................................................................................................
MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .......................
FUB-AMB,
MMBFUBINACA,
AMB-FUBINACA
(2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ..........................................
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ....................................................................
5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) .........................
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide .................
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) .........
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ...............................................
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ........
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ..................................
5F-EDMB-PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...........................
5F-MDMB-PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ................................
MDMB-CHMICA,
MMB-CHMINACA
(Methyl
2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3dimethylbutanoate).
MMB-CHMICA, AMB-CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) .........
FUB-AKB48, FUB-APINACA, AKB48 N-(4-FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole3-carboximide).
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ..............................................................
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ....................................
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ...................................................................................................
5F-CUMYL-PINACA, 5GT-25 (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) ......................
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) .................
4-CN-CUML-BUTINACA, 4-cyano-CUMYL-BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78 (1(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide).
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ......................................................................
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ..............................................................................
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ......................................................................................................
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ..................................................................
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ........................................................................................................................
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ...........................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) .......................................................................................................
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ......................................................................................................
NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate ..........................................................
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ..................................................................................................
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ..............................................................................
4-MEAP (4-Methyl-alpha-ethylaminopentiophenone) ......................................................................................................
N-Ethylhexedrone ............................................................................................................................................................
Alpha-ethyltryptamine ......................................................................................................................................................
Ibogaine ...........................................................................................................................................................................
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) .................................................................
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ...........................................
Lysergic acid diethylamide ..............................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) ................................................................................................
Marihuana Extract ...........................................................................................................................................................
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Parahexyl .........................................................................................................................................................................
VerDate Sep<11>2014
18:19 Aug 08, 2023
Jkt 259001
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
E:\FR\FM\09AUN1.SGM
09AUN1
Schedule
1219
1227
1233
1235
1237
1238
1246
1248
1249
1258
1475
1478
1480
1503
1585
1590
2010
2565
2572
6250
7008
7010
7011
7012
7014
7019
7020
7021
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
7023
7024
7025
7031
7032
7033
7034
7035
7036
7041
7042
I
I
I
I
I
I
I
I
I
I
I
7044
7047
I
I
7048
7049
7081
7083
7085
7089
I
I
I
I
I
I
7104
7118
7122
7144
7173
7200
7201
7203
7221
7222
7225
7245
7246
7249
7260
7297
7298
7315
7348
7350
7360
7370
7374
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
53919
Federal Register / Vol. 88, No. 152 / Wednesday, August 9, 2023 / Notices
lotter on DSK11XQN23PROD with NOTICES1
Controlled substance
Drug code
Mescaline .........................................................................................................................................................................
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2 ) ............................................................................................
3,4,5-Trimethoxyamphetamine ........................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .............................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..........................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .............................................................................................................................
2,5-Dimethoxyamphetamine ............................................................................................................................................
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ......................................................................................................
2,5-Dimethoxy-4-ethylamphetamine ................................................................................................................................
3,4-Methylenedioxyamphetamine ....................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ..................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ..................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine .......................................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
4-Methoxyamphetamine ..................................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine .................................................................................................................................
Alpha-methyltryptamine ...................................................................................................................................................
Bufotenine ........................................................................................................................................................................
Diethyltryptamine .............................................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
Psilocybin .........................................................................................................................................................................
Psilocyn ...........................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine .............................................................................................................................
4′-Chloro-alpha-pyrrolidinovalerophenone .......................................................................................................................
MPHP, 4′-Methyl-alpha-pyrrolidinohexiophenone ...........................................................................................................
N-Ethyl-1-phenylcyclohexylamine ....................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ....................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ...............................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ..............................................................................................................................
N-Ethyl-3-piperidyl benzilate ............................................................................................................................................
N-Methyl-3-piperidyl benzilate .........................................................................................................................................
N-Benzylpiperazine ..........................................................................................................................................................
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) .....................................................................................................
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) ..................................................................................................
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E ) ....................................................................................................
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) .................................................................................................................
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) ........................................................................................................
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) ...................................................................................................
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) .....................................................................................................
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P) ..............................................................................................
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4 ) ....................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) .......................................................................................................................
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe) .....................................................
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe) .....................................................
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe) ..........................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ......................................................................................................
Butylone ...........................................................................................................................................................................
Pentylone .........................................................................................................................................................................
N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) .....................................................
a-PHP, alpha-Pyrrolidinohexanophenone .......................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) ........................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) ..........................................................................................................................
Ethylone ...........................................................................................................................................................................
Eutylone ...........................................................................................................................................................................
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ....................................................................................................
Acetyldihydrocodeine .......................................................................................................................................................
Benzylmorphine ...............................................................................................................................................................
Codeine-N-oxide ..............................................................................................................................................................
Cyprenorphine .................................................................................................................................................................
Desomorphine .................................................................................................................................................................
Etorphine (except HCl) ....................................................................................................................................................
Codeine methylbromide ...................................................................................................................................................
Brorphine .........................................................................................................................................................................
Dihydromorphine .............................................................................................................................................................
Difenoxin ..........................................................................................................................................................................
Heroin ..............................................................................................................................................................................
Hydromorphinol ...............................................................................................................................................................
Methyldesorphine ............................................................................................................................................................
Methyldihydromorphine ...................................................................................................................................................
Morphine methylbromide .................................................................................................................................................
Morphine methylsulfonate ...............................................................................................................................................
Morphine-N-oxide ............................................................................................................................................................
Myrophine ........................................................................................................................................................................
Nicocodeine .....................................................................................................................................................................
VerDate Sep<11>2014
18:19 Aug 08, 2023
Jkt 259001
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
E:\FR\FM\09AUN1.SGM
09AUN1
7381
7385
7390
7391
7392
7395
7396
7398
7399
7400
7401
7402
7404
7405
7411
7431
7432
7433
7434
7435
7437
7438
7439
7443
7446
7455
7458
7470
7473
7482
7484
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7543
7544
7545
7546
7547
7549
7694
9051
9052
9053
9054
9055
9056
9070
9098
9145
9168
9200
9301
9302
9304
9305
9306
9307
9308
9309
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
53920
Federal Register / Vol. 88, No. 152 / Wednesday, August 9, 2023 / Notices
lotter on DSK11XQN23PROD with NOTICES1
Controlled substance
Drug code
Nicomorphine ...................................................................................................................................................................
Normorphine ....................................................................................................................................................................
Pholcodine .......................................................................................................................................................................
Thebacon .........................................................................................................................................................................
Acetorphine ......................................................................................................................................................................
Drotebanol .......................................................................................................................................................................
U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ...............................................................
AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ..................................................................
MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) ...................................................................................................
Acetylmethadol ................................................................................................................................................................
Allylprodine ......................................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol ......................................................................................................
Alphameprodine ...............................................................................................................................................................
Alphamethadol .................................................................................................................................................................
Benzethidine ....................................................................................................................................................................
Betacetylmethadol ...........................................................................................................................................................
Betameprodine ................................................................................................................................................................
Betamethadol ...................................................................................................................................................................
Betaprodine .....................................................................................................................................................................
Clonitazene ......................................................................................................................................................................
Dextromoramide ..............................................................................................................................................................
Isotonitazene ...................................................................................................................................................................
Diampromide ...................................................................................................................................................................
Diethylthiambutene ..........................................................................................................................................................
Dimenoxadol ....................................................................................................................................................................
Dimepheptanol .................................................................................................................................................................
Dimethylthiambutene .......................................................................................................................................................
Dioxaphetyl butyrate ........................................................................................................................................................
Dipipanone .......................................................................................................................................................................
Ethylmethylthiambutene ..................................................................................................................................................
Etonitazene ......................................................................................................................................................................
Etoxeridine .......................................................................................................................................................................
Furethidine .......................................................................................................................................................................
Hydroxypethidine .............................................................................................................................................................
Ketobemidone ..................................................................................................................................................................
Levomoramide .................................................................................................................................................................
Levophenacylmorphan ....................................................................................................................................................
Morpheridine ....................................................................................................................................................................
Noracymethadol ...............................................................................................................................................................
Norlevorphanol ................................................................................................................................................................
Normethadone .................................................................................................................................................................
Norpipanone ....................................................................................................................................................................
Phenadoxone ...................................................................................................................................................................
Phenampromide ..............................................................................................................................................................
Phenoperidine ..................................................................................................................................................................
Piritramide ........................................................................................................................................................................
Proheptazine ....................................................................................................................................................................
Properidine ......................................................................................................................................................................
Racemoramide ................................................................................................................................................................
Trimeperidine ...................................................................................................................................................................
Phenomorphan ................................................................................................................................................................
Propiram ..........................................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine ......................................................................................................................
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine ..............................................................................................................
Tilidine .............................................................................................................................................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) .................................................................................
Para-Fluorofentanyl .........................................................................................................................................................
3-Methylfentanyl ..............................................................................................................................................................
Alpha-methylfentanyl .......................................................................................................................................................
Acetyl-alpha-methylfentanyl .............................................................................................................................................
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide .......................................................................................
Para-Methylfentanyl .........................................................................................................................................................
4′-Methyl Acetyl Fentanyl ................................................................................................................................................
Ortho-Methyl Methoxyacetyl Fentanyl .............................................................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ...............................................................................
Butyryl Fentanyl ...............................................................................................................................................................
Para-fluorobutyryl fentanyl ...............................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) .........................................
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide .........................................................................................
Para-chloroisobutyryl fentanyl .........................................................................................................................................
Isobutyryl fentanyl ............................................................................................................................................................
Beta-hydroxyfentanyl .......................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ........................................................................................................................................
Alpha-methylthiofentanyl .................................................................................................................................................
VerDate Sep<11>2014
18:19 Aug 08, 2023
Jkt 259001
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
E:\FR\FM\09AUN1.SGM
09AUN1
9312
9313
9314
9315
9319
9335
9547
9551
9560
9601
9602
9603
9604
9605
9606
9607
9608
9609
9611
9612
9613
9614
9615
9616
9617
9618
9619
9621
9622
9623
9624
9625
9626
9627
9628
9629
9631
9632
9633
9634
9635
9636
9637
9638
9641
9642
9643
9644
9645
9646
9647
9649
9661
9663
9750
9811
9812
9813
9814
9815
9816
9817
9819
9820
9821
9822
9823
9824
9825
9826
9827
9830
9831
9832
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
53921
Federal Register / Vol. 88, No. 152 / Wednesday, August 9, 2023 / Notices
lotter on DSK11XQN23PROD with NOTICES1
Controlled substance
Drug code
3-Methylthiofentanyl .........................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .............................................................
Thiofentanyl .....................................................................................................................................................................
Beta-hydroxythiofentanyl .................................................................................................................................................
Para-methoxybutyryl fentanyl ..........................................................................................................................................
Ocfentanil .........................................................................................................................................................................
Thiofuranyl Fentanyl ........................................................................................................................................................
Valeryl fentanyl ................................................................................................................................................................
Phenyl fentanyl ................................................................................................................................................................
Beta′-Phenyl fentanyl ......................................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ..........................................................................
Crotonyl Fentanyl ............................................................................................................................................................
Cyclopropyl Fentanyl .......................................................................................................................................................
Ortho-Fluorobutyryl Fentanyl ...........................................................................................................................................
Cyclopentyl Fentanyl .......................................................................................................................................................
Ortho-Methyl Acetylfentanyl ............................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) .....................................................................................
Fentanyl Carbamate ........................................................................................................................................................
Ortho-Fluoracryl Fentanyl ................................................................................................................................................
Ortho-Fluoroisobutyryl Fentanyl ......................................................................................................................................
Para-Fluoro Furanyl Fentanyl ..........................................................................................................................................
2′-Fluoro ortho-fluorofentanyl ..........................................................................................................................................
Beta-Methyl Fentanyl .......................................................................................................................................................
Zipeprol ............................................................................................................................................................................
Amphetamine ...................................................................................................................................................................
Methamphetamine ...........................................................................................................................................................
Lisdexamfetamine ............................................................................................................................................................
Phenmetrazine .................................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
Secobarbital .....................................................................................................................................................................
Glutethimide .....................................................................................................................................................................
Nabilone ...........................................................................................................................................................................
1-Phenylcyclohexylamine ................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .....................................................................................................................
Norfentanyl ......................................................................................................................................................................
Phenylacetone .................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ................................................................................................................................
Alphaprodine ....................................................................................................................................................................
Anileridine ........................................................................................................................................................................
Cocaine ............................................................................................................................................................................
Codeine ...........................................................................................................................................................................
Etorphine HCl ..................................................................................................................................................................
Dihydrocodeine ................................................................................................................................................................
Oxycodone .......................................................................................................................................................................
Hydromorphone ...............................................................................................................................................................
Diphenoxylate ..................................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Ethylmorphine ..................................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Levomethorphan ..............................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Isomethadone ..................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Meperidine intermediate-A ..............................................................................................................................................
Meperidine intermediate-B ..............................................................................................................................................
Meperidine intermediate-C ..............................................................................................................................................
Metazocine ......................................................................................................................................................................
Oliceridine ........................................................................................................................................................................
Methadone .......................................................................................................................................................................
Methadone intermediate ..................................................................................................................................................
Metopon ...........................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..............................................................................................................
Morphine ..........................................................................................................................................................................
Oripavine .........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Dihydroetorphine .............................................................................................................................................................
Levo-alphacetylmethadol .................................................................................................................................................
Oxymorphone ..................................................................................................................................................................
Noroxymorphone .............................................................................................................................................................
Phenazocine ....................................................................................................................................................................
Thiafentanil ......................................................................................................................................................................
VerDate Sep<11>2014
18:19 Aug 08, 2023
Jkt 259001
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
E:\FR\FM\09AUN1.SGM
09AUN1
9833
9834
9835
9836
9837
9838
9839
9840
9841
9842
9843
9844
9845
9846
9847
9848
9850
9851
9852
9853
9854
9855
9856
9873
1100
1105
1205
1631
1724
2125
2270
2315
2550
7379
7460
7471
8333
8366
8501
8603
9010
9020
9041
9050
9059
9120
9143
9150
9170
9180
9190
9193
9210
9220
9226
9230
9232
9233
9234
9240
9245
9250
9254
9260
9273
9300
9330
9333
9334
9648
9652
9668
9715
9729
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
53922
Federal Register / Vol. 88, No. 152 / Wednesday, August 9, 2023 / Notices
Controlled substance
Drug code
Piminodine .......................................................................................................................................................................
Racemethorphan .............................................................................................................................................................
Racemorphan ..................................................................................................................................................................
Alfentanil ..........................................................................................................................................................................
Remifentanil .....................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
Carfentanil .......................................................................................................................................................................
Tapentadol .......................................................................................................................................................................
Bezitramide ......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
Moramide-intermediate ....................................................................................................................................................
The company plans to bulk
manufacture the listed controlled
substances for distribution to its
customers. In reference to dug codes
7360 (Marihuana), and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic. No other activities for these
drug codes are authorized for this
registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–17036 Filed 8–8–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1241]
Importer of Controlled Substances
Application: Cambrex Charles City
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Cambrex Charles City has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before September 8, 2023. Such
persons may also file a written request
for a hearing on the application on or
before September 8, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:19 Aug 08, 2023
Jkt 259001
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on July 3, 2023, Cambrex
Charles City, 1205 11th Street, Charles
City, Iowa 50616–3466, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
Controlled
substance
Drug
code
Psilocybin ..............................
4-Anilino-N-phenethyl-4-piperidine (ANPP).
Phenylacetone ......................
Cocoa Leaves .......................
Opium Raw ...........................
Poppy Straw Concentrate .....
Schedule
7437
8333
I
II
8501
9040
9600
9670
II
II
II
II
The company plans to import
psilocybin for formulation development
and clinical trial support for their
customers. The remaining listed
controlled substances will be imported
to support the manufacture into other
controlled substances which will be
distributed to their customers. No other
activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
9730
9732
9733
9737
9739
9740
9743
9780
9800
9801
9802
Schedule
II
II
II
II
II
II
II
II
II
II
II
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–17038 Filed 8–8–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1231]
Bulk Manufacturer of Controlled
Substances Application: Cambrex
High Point, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Cambrex High Point, Inc. has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before October 10, 2023. Such
persons may also file a written request
for a hearing on the application on or
before October 10, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
SUMMARY:
E:\FR\FM\09AUN1.SGM
09AUN1
]]>Agencies
[Federal Register Volume 88, Number 152 (Wednesday, August 9, 2023)]
[Notices]
[Pages 53917-53922]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-17036]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1238]
Bulk Manufacturer of Controlled Substances Application: Chemtos,
LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Chemtos, LLC has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
October 10, 2023. Such persons may also file a written request for a
hearing on the application on or before October 10, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on July 6, 2023, Chemtos, LLC., 16713 Picadilly Court,
Round Rock, Texas 78664-8544, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled
substance(s):
[[Page 53918]]
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Amineptine......................... 1219 I
Mesocarb........................... 1227 I
3-Fluoro-N-methylcathinone (3-FMC). 1233 I
Cathinone.......................... 1235 I
Methcathinone...................... 1237 I
4-Fluoro-N-methylcathinone (4-FMC). 1238 I
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
Mephedrone (4-Methyl-N- 1248 I
methylcathinone).
4-Methyl-N-ethylcathinone (4-MEC).. 1249 I
Naphyrone.......................... 1258 I
N-Ethylamphetamine................. 1475 I
Methiopropamine.................... 1478 I
N,N-Dimethylamphetamine............ 1480 I
Fenethylline....................... 1503 I
Aminorex........................... 1585 I
4-Methylaminorex (cis isomer)...... 1590 I
Gamma Hydroxybutyric Acid.......... 2010 I
Methaqualone....................... 2565 I
Mecloqualone....................... 2572 I
JWH-250 (1-Pentyl-3-(2- 6250 I
methoxyphenylacetyl) indole).
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-
methoxyphenylacetyl) indole).
ADB-FUBINACA (N-(1-amino-3,3- 7010 I
dimethyl-1-oxobutan-2-yl)-1-(4-
fluorobenzyl)-1H-indazole-3-
carboxamide).
5-Fluoro-UR-144 and XLR11 [1-(5- 7011 I
Fluoro-pentyl)1H-indol-3-
yl](2,2,3,3-
tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1- 7012 I
oxobutan-2-yl)-1-(4-fluorobenzyl)-
1H-indazole-3-carboxamide).
FUB-144 (1-(4-fluorobenzyl)-1H- 7014 I
indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone).
JWH-019 (1-Hexyl-3-(1- 7019 I
naphthoyl)indole).
MDMB-FUBINACA (Methyl 2-(1-(4- 7020 I
fluorobenzyl)-1H-indazole-3-
carboxamido)-3,3-
dimethylbutanoate).
FUB-AMB, MMB- FUBINACA, AMB- 7021 I
FUBINACA (2-(1-(4-fluorobenzyl)-
1Hindazole-3-carboxamido)-3-
methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-1- 7023 I
oxobutan-2-yl)-1-pentyl-1H-
indazole-3-carboxamide).
THJ-2201 [1-(5-fluoropentyl)-1H- 7024 I
indazol-3-yl](naphthalen-1-
yl)methanone.
5F-AB-PINACA (N-(1-amino-3-methyl-1- 7025 I
oxobutan-2-yl)-1-(5-fluropentyl)-
1H-indazole-3-carboximide).
AB-CHMINACA (N-(1-amino-3-methyl-1- 7031 I
oxobutan-2-yl)-1-
(cyclohexylmethyl)-1H-indazole-3-
carboxamide.
MAB-CHMINACA (N-(1-amino- 7032 I
3,3dimethyl-1-oxobutan-2-yl)-1-
(cyclohexylmethyl)-1H-indazole-3-
carboxamide).
5F-AMB (Methyl 2-(1-(5- 7033 I
fluoropentyl)-1H-indazole-3-
carboxamido)-3-methylbutanoate).
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1- 7034 I
(5-fluoropentyl)-1H-indazole-3-
carboxamido)-3,3-
dimethylbutanoate).
ADB-PINACA (N-(1-amino-3,3-dimethyl- 7035 I
1-oxobutan-2-yl)-1-pentyl-1H-
indazole-3-carboxamide).
5F-EDMB-PINACA (ethyl 2-(1-(5- 7036 I
fluoropentyl)-1H-indazole-3-
carboxamido)-3,3-
dimethylbutanoate).
5F-MDMB-PICA (methyl 2-(1-(5- 7041 I
fluoropentyl)-1H-indole-3-
carboxamido)-3,3-
dimethylbutanoate).
MDMB-CHMICA, MMB-CHMINACA (Methyl 2- 7042 I
(1-(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3,3-
dimethylbutanoate).
MMB-CHMICA, AMB-CHMICA (methyl 2-(1- 7044 I
(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3-methylbutanoate).
FUB-AKB48, FUB-APINACA, AKB48 N-(4- 7047 I
FLUOROBENZYL) (N-(adamantan-1-yl)-
1-(4-fluorobenzyl)-1H-indazole-3-
carboximide).
APINACA and AKB48 N-(1-Adamantyl)-1- 7048 I
pentyl-1H-indazole-3-carboxamide.
5F-APINACA, 5F-AKB48 (N-(adamantan- 7049 I
1-yl)-1-(5-fluoropentyl)-1H-
indazole-3-carboxamide).
JWH-081 (1-Pentyl-3-(1-(4- 7081 I
methoxynaphthoyl) indole).
5F-CUMYL-PINACA, 5GT-25 (1-(5- 7083 I
fluoropentyl)-N-(2-phenylpropan-2-
yl)-1H-indazole-3-carboxamide).
5F-CUMYL-P7AICA (1-(5-fluoropentyl)- 7085 I
N-(2-phenylpropan-2-yl)-1H-
pyrrolo[2,3-b]pyridine-3-
carboxamide).
4-CN-CUML-BUTINACA, 4-cyano-CUMYL- 7089 I
BUTINACA, 4-CN-CUMYL BINACA, CUMYL-
4CN-BINACA, SGT-78 (1-(4-
cyanobutyl)-N-(2-phenylpropan-2-
yl)-1H-indazole-3-carboxamide).
SR-19 (Also known as RCS-4) (1- 7104 I
Pentyl-3-[(4-methoxy)-benzoyl]
indole.
JWH-018 (also known as AM678) (1- 7118 I
Pentyl-3-(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I
naphthoyl) indole).
UR-144 (1-Pentyl-1H-indol-3- 7144 I
yl)(2,2,3,3-
tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1- 7173 I
naphthoyl)indole).
JWH-200 (1-[2-(4-Morpholinyl)ethyl]- 7200 I
3-(1-naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I
naphthoyl) indole).
JWH-203 (1-Pentyl-3-(2- 7203 I
chlorophenylacetyl) indole).
NM2201, CBL2201 (Naphthalen-1-yl 1- 7221 I
(5-fluoropentyl)-1H-indole-3-
carboxylate.
PB-22 (Quinolin-8-yl 1-pentyl-1H- 7222 I
indole-3-carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5- 7225 I
fluoropentyl)-1H-indole-3-
carboxylate).
4-MEAP (4-Methyl-alpha- 7245 I
ethylaminopentiophenone).
N-Ethylhexedrone................... 7246 I
Alpha-ethyltryptamine.............. 7249 I
Ibogaine........................... 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I
[(1R,3S)-3-hydroxycyclohexyl-
phenol).
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol).
Lysergic acid diethylamide......... 7315 I
2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine (2C-T-7).
Marihuana Extract.................. 7350 I
Marihuana.......................... 7360 I
Tetrahydrocannabinols.............. 7370 I
Parahexyl.......................... 7374 I
[[Page 53919]]
Mescaline.......................... 7381 I
2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I
ethanamine (2C-T-2 ).
3,4,5-Trimethoxyamphetamine........ 7390 I
4-Bromo-2,5-dimethoxyamphetamine... 7391 I
4-Bromo-2,5-dimethoxyphenethylamine 7392 I
4-Methyl-2,5-dimethoxyamphetamine.. 7395 I
2,5-Dimethoxyamphetamine........... 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I
naphthoyl) indole).
2,5-Dimethoxy-4-ethylamphetamine... 7399 I
3,4-Methylenedioxyamphetamine...... 7400 I
5-Methoxy-3,4- 7401 I
methylenedioxyamphetamine.
N-Hydroxy-3,4- 7402 I
methylenedioxyamphetamine.
3,4-Methylenedioxy-N- 7404 I
ethylamphetamine.
3,4-Methylenedioxymethamphetamine.. 7405 I
4-Methoxyamphetamine............... 7411 I
5-Methoxy-N-N-dimethyltryptamine... 7431 I
Alpha-methyltryptamine............. 7432 I
Bufotenine......................... 7433 I
Diethyltryptamine.................. 7434 I
Dimethyltryptamine................. 7435 I
Psilocybin......................... 7437 I
Psilocyn........................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine 7439 I
4'-Chloro-alpha- 7443 I
pyrrolidinovalerophenone.
MPHP, 4'-Methyl-alpha- 7446 I
pyrrolidinohexiophenone.
N-Ethyl-1-phenylcyclohexylamine.... 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine.. 7458 I
1-[1-(2- 7470 I
Thienyl)cyclohexyl]piperidine.
1-[1-(2- 7473 I
Thienyl)cyclohexyl]pyrrolidine.
N-Ethyl-3-piperidyl benzilate...... 7482 I
N-Methyl-3-piperidyl benzilate..... 7484 I
N-Benzylpiperazine................. 7493 I
4-Methyl- 7498 I
alphapyrrolidinopropiophenone (4-
MePPP).
2-(2,5-Dimethoxy-4-methylphenyl) 7508 I
ethanamine (2C-D).
2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I
ethanamine (2C-E ).
2-(2,5-Dimethoxyphenyl) ethanamine 7517 I
(2C-H).
2-(4-iodo-2,5-dimethoxyphenyl) 7518 I
ethanamine (2C-I).
2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I
ethanamine (2C-C).
2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I
ethanamine (2C-N).
2-(2,5-Dimethoxy-4-(n)- 7524 I
propylphenyl) ethanamine (2C-P).
2-(4-Isopropylthio)-2,5- 7532 I
dimethoxyphenyl) ethanamine (2C-T-
4 ).
MDPV (3,4- 7535 I
Methylenedioxypyrovalerone).
2-(4-bromo-2,5-dimethoxyphenyl)-N- 7536 I
(2-methoxybenzyl) ethanamine (25B-
NBOMe).
2-(4-chloro-2,5-dimethoxyphenyl)-N- 7537 I
(2-methoxybenzyl) ethanamine (25C-
NBOMe).
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- 7538 I
methoxybenzyl) ethanamine (25I-
NBOMe).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone........................... 7541 I
Pentylone.......................... 7542 I
N-Ethypentylone, ephylone (1-(1,3- 7543 I
benzodioxol-5-yl)-2-(ethylamino)-
pentan-1-one).
[alpha]-PHP, alpha- 7544 I
Pyrrolidinohexanophenone.
alpha-pyrrolidinopentiophenone 7545 I
([alpha]-PVP).
alpha-pyrrolidinobutiophenone 7546 I
([alpha]-PBP).
Ethylone........................... 7547 I
Eutylone........................... 7549 I
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl) indole).
Acetyldihydrocodeine............... 9051 I
Benzylmorphine..................... 9052 I
Codeine-N-oxide.................... 9053 I
Cyprenorphine...................... 9054 I
Desomorphine....................... 9055 I
Etorphine (except HCl)............. 9056 I
Codeine methylbromide.............. 9070 I
Brorphine.......................... 9098 I
Dihydromorphine.................... 9145 I
Difenoxin.......................... 9168 I
Heroin............................. 9200 I
Hydromorphinol..................... 9301 I
Methyldesorphine................... 9302 I
Methyldihydromorphine.............. 9304 I
Morphine methylbromide............. 9305 I
Morphine methylsulfonate........... 9306 I
Morphine-N-oxide................... 9307 I
Myrophine.......................... 9308 I
Nicocodeine........................ 9309 I
[[Page 53920]]
Nicomorphine....................... 9312 I
Normorphine........................ 9313 I
Pholcodine......................... 9314 I
Thebacon........................... 9315 I
Acetorphine........................ 9319 I
Drotebanol......................... 9335 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]ben
zamide)).
MT-45 (1-cyclohexyl-4-(1,2- 9560 I
diphenylethyl)piperazine)).
Acetylmethadol..................... 9601 I
Allylprodine....................... 9602 I
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.
Alphameprodine..................... 9604 I
Alphamethadol...................... 9605 I
Benzethidine....................... 9606 I
Betacetylmethadol.................. 9607 I
Betameprodine...................... 9608 I
Betamethadol....................... 9609 I
Betaprodine........................ 9611 I
Clonitazene........................ 9612 I
Dextromoramide..................... 9613 I
Isotonitazene...................... 9614 I
Diampromide........................ 9615 I
Diethylthiambutene................. 9616 I
Dimenoxadol........................ 9617 I
Dimepheptanol...................... 9618 I
Dimethylthiambutene................ 9619 I
Dioxaphetyl butyrate............... 9621 I
Dipipanone......................... 9622 I
Ethylmethylthiambutene............. 9623 I
Etonitazene........................ 9624 I
Etoxeridine........................ 9625 I
Furethidine........................ 9626 I
Hydroxypethidine................... 9627 I
Ketobemidone....................... 9628 I
Levomoramide....................... 9629 I
Levophenacylmorphan................ 9631 I
Morpheridine....................... 9632 I
Noracymethadol..................... 9633 I
Norlevorphanol..................... 9634 I
Normethadone....................... 9635 I
Norpipanone........................ 9636 I
Phenadoxone........................ 9637 I
Phenampromide...................... 9638 I
Phenoperidine...................... 9641 I
Piritramide........................ 9642 I
Proheptazine....................... 9643 I
Properidine........................ 9644 I
Racemoramide....................... 9645 I
Trimeperidine...................... 9646 I
Phenomorphan....................... 9647 I
Propiram........................... 9649 I
1-Methyl-4-phenyl-4- 9661 I
propionoxypiperidine.
1-(2-Phenylethyl)-4-phenyl-4- 9663 I
acetoxypiperidine.
Tilidine........................... 9750 I
Acryl fentanyl (N-(1- 9811 I
phenethylpiperidin-4-yl)-N-
phenylacrylamide).
Para-Fluorofentanyl................ 9812 I
3-Methylfentanyl................... 9813 I
Alpha-methylfentanyl............... 9814 I
Acetyl-alpha-methylfentanyl........ 9815 I
N-(2-fluorophenyl)-N-(1- 9816 I
phenethylpiperidin-4-
yl)propionamide.
Para-Methylfentanyl................ 9817 I
4'-Methyl Acetyl Fentanyl.......... 9819 I
Ortho-Methyl Methoxyacetyl Fentanyl 9820 I
Acetyl Fentanyl (N-(1- 9821 I
phenethylpiperidin-4-yl)-N-
phenylacetamide).
Butyryl Fentanyl................... 9822 I
Para-fluorobutyryl fentanyl........ 9823 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-
phenethylpiperidin-4-
yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4- 9825 I
yl)-N-phenylacetamide.
Para-chloroisobutyryl fentanyl..... 9826 I
Isobutyryl fentanyl................ 9827 I
Beta-hydroxyfentanyl............... 9830 I
Beta-hydroxy-3-methylfentanyl...... 9831 I
Alpha-methylthiofentanyl........... 9832 I
[[Page 53921]]
3-Methylthiofentanyl............... 9833 I
Furanyl fentanyl (N-(1- 9834 I
phenethylpiperidin-4-yl)-N-
phenylfuran-2-carboxamide).
Thiofentanyl....................... 9835 I
Beta-hydroxythiofentanyl........... 9836 I
Para-methoxybutyryl fentanyl....... 9837 I
Ocfentanil......................... 9838 I
Thiofuranyl Fentanyl............... 9839 I
Valeryl fentanyl................... 9840 I
Phenyl fentanyl.................... 9841 I
Beta'-Phenyl fentanyl.............. 9842 I
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-
carboxamide.
Crotonyl Fentanyl.................. 9844 I
Cyclopropyl Fentanyl............... 9845 I
Ortho-Fluorobutyryl Fentanyl....... 9846 I
Cyclopentyl Fentanyl............... 9847 I
Ortho-Methyl Acetylfentanyl........ 9848 I
Fentanyl related-compounds as 9850 I
defined in 21 CFR 1308.11(h).
Fentanyl Carbamate................. 9851 I
Ortho-Fluoracryl Fentanyl.......... 9852 I
Ortho-Fluoroisobutyryl Fentanyl.... 9853 I
Para-Fluoro Furanyl Fentanyl....... 9854 I
2'-Fluoro ortho-fluorofentanyl..... 9855 I
Beta-Methyl Fentanyl............... 9856 I
Zipeprol........................... 9873 I
Amphetamine........................ 1100 II
Methamphetamine.................... 1105 II
Lisdexamfetamine................... 1205 II
Phenmetrazine...................... 1631 II
Methylphenidate.................... 1724 II
Amobarbital........................ 2125 II
Pentobarbital...................... 2270 II
Secobarbital....................... 2315 II
Glutethimide....................... 2550 II
Nabilone........................... 7379 II
1-Phenylcyclohexylamine............ 7460 II
Phencyclidine...................... 7471 II
4-Anilino-N-phenethyl-4-piperidine 8333 II
(ANPP).
Norfentanyl........................ 8366 II
Phenylacetone...................... 8501 II
1-Piperidinocyclohexanecarbonitrile 8603 II
Alphaprodine....................... 9010 II
Anileridine........................ 9020 II
Cocaine............................ 9041 II
Codeine............................ 9050 II
Etorphine HCl...................... 9059 II
Dihydrocodeine..................... 9120 II
Oxycodone.......................... 9143 II
Hydromorphone...................... 9150 II
Diphenoxylate...................... 9170 II
Ecgonine........................... 9180 II
Ethylmorphine...................... 9190 II
Hydrocodone........................ 9193 II
Levomethorphan..................... 9210 II
Levorphanol........................ 9220 II
Isomethadone....................... 9226 II
Meperidine......................... 9230 II
Meperidine intermediate-A.......... 9232 II
Meperidine intermediate-B.......... 9233 II
Meperidine intermediate-C.......... 9234 II
Metazocine......................... 9240 II
Oliceridine........................ 9245 II
Methadone.......................... 9250 II
Methadone intermediate............. 9254 II
Metopon............................ 9260 II
Dextropropoxyphene, bulk (non- 9273 II
dosage forms).
Morphine........................... 9300 II
Oripavine.......................... 9330 II
Thebaine........................... 9333 II
Dihydroetorphine................... 9334 II
Levo-alphacetylmethadol............ 9648 II
Oxymorphone........................ 9652 II
Noroxymorphone..................... 9668 II
Phenazocine........................ 9715 II
Thiafentanil....................... 9729 II
[[Page 53922]]
Piminodine......................... 9730 II
Racemethorphan..................... 9732 II
Racemorphan........................ 9733 II
Alfentanil......................... 9737 II
Remifentanil....................... 9739 II
Sufentanil......................... 9740 II
Carfentanil........................ 9743 II
Tapentadol......................... 9780 II
Bezitramide........................ 9800 II
Fentanyl........................... 9801 II
Moramide-intermediate.............. 9802 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for distribution to its customers. In reference to dug codes
7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans
to bulk manufacture these drugs as synthetic. No other activities for
these drug codes are authorized for this registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-17036 Filed 8-8-23; 8:45 am]
BILLING CODE P
